Bluejay Diagnostics (BJDX) Gains from Investment Securities (2022 - 2023)
Historic Gains from Investment Securities for Bluejay Diagnostics (BJDX) over the last 2 years, with Q4 2023 value amounting to -$1.0.
- Bluejay Diagnostics' Gains from Investment Securities fell 10005.77% to -$1.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $57736.0, marking a year-over-year increase of 30682.07%. This contributed to the annual value of $6594.0 for FY2024, which is 8883.85% down from last year.
- Latest data reveals that Bluejay Diagnostics reported Gains from Investment Securities of -$1.0 as of Q4 2023, which was down 10005.77% from $31361.0 recorded in Q3 2023.
- Bluejay Diagnostics' Gains from Investment Securities' 5-year high stood at $57601.0 during Q1 2023, with a 5-year trough of -$1596.0 in Q3 2022.